Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Income from Non-Controlling Interests (2016 - 2021)

Historic Income from Non-Controlling Interests for iBio (IBIO) over the last 6 years, with Q3 2021 value amounting to -$1000.0.

  • iBio's Income from Non-Controlling Interests changed 0.0% to -$1000.0 in Q3 2021 from the same period last year, while for Jun 2022 it was -$1000.0, marking a year-over-year increase of 8333.33%. This contributed to the annual value of -$1000.0 for FY2022, which is 8333.33% up from last year.
  • As of Q3 2021, iBio's Income from Non-Controlling Interests stood at -$1000.0, which was down 0.0% from -$2000.0 recorded in Q2 2021.
  • In the past 5 years, iBio's Income from Non-Controlling Interests registered a high of -$1000.0 during Q2 2017, and its lowest value of -$492000.0 during Q1 2017.
  • Its 5-year average for Income from Non-Controlling Interests is -$30117.6, with a median of -$1000.0 in 2017.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first surged by 9982.24% in 2017, then plummeted by 10000.0% in 2019.
  • Over the past 5 years, iBio's Income from Non-Controlling Interests (Quarter) stood at -$1000.0 in 2017, then changed by 0.0% to -$1000.0 in 2018, then crashed by 100.0% to -$2000.0 in 2019, then changed by 0.0% to -$2000.0 in 2020, then skyrocketed by 50.0% to -$1000.0 in 2021.
  • Its Income from Non-Controlling Interests stands at -$1000.0 for Q3 2021, versus -$2000.0 for Q2 2021 and -$1000.0 for Q1 2021.